Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase — Trials · CancerIndex

Clinical trials

Registered studies

28 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7
Recruiting: 3
Ph III recruiting: 1
Growth YoY: —
Industry share: 57%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07469891	A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms	recruiting	Phase 1	100	Prelude Therapeutics IncorporatedINDUSTRY	2	Sep 18, 2026	clinicaltrials
NCT03862157	Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia	active not recruiting	Phase 1 / Phase 2	40	M.D. Anderson Cancer CenterOTHER	1	Jul 16, 2026	clinicaltrials